Causes found for stiff skin conditions

Mar 19, 2010

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems. The findings, which appear this week in Science Translational Medicine, open doors to testing new treatments.

"Scleroderma is a common and often devastating condition yet its cause remains mysterious. My greatest hope is that this work will facilitate the development of new and better treatments," says Harry C. Dietz, M.D., the Victor A. McKusick Professor of Genetics and director of the Johns Hopkins William S. Smilow Center for Marfan Syndrome Research.

Also known as systemic sclerosis, scleroderma generally affects previously healthy young adults, causing scarring of skin and that can lead to heart and lung failure. "Most often individuals with scleroderma do not have other affected family members, precluding use of genetic techniques to map the underlying genes. Instead we turned to a rare but inherited form of isolated skin called stiff skin syndrome, hoping to gain a foothold regarding cellular mechanisms that might prove relevant to both conditions," says Dietz.

A number of clues led Dietz and his team to strongly suspect a role for the connective tissue protein fibrillin-1 in these skin conditions. First, excess is a hallmark feature of both stiff skin syndrome and scleroderma. While studying Marfan syndrome, a condition caused by a deficiency of fibrillin-1, the researchers discovered that fibrillin-1 regulates the activity of TGFbeta, a molecule that induces cells to make more collagen. Second, other researchers have shown that duplication of a segment within the fibrillin-1 gene is associated with skin fibrosis in mice. And third, Dietz treated a patient at Johns Hopkins who had both stiff skin syndrome and eye problems associated with Marfan syndrome. "This seemed too much of a coincidence," he says.

So Dietz's team examined patients with stiff skin syndrome and found them to have excessive amounts of fibrillin-1 in the skin. The researchers then sequenced the fibrillin-1 gene in these same patients and found all the stiff skin syndrome mutations clustered in a single region of the fibrillin-1 protein known to interact with neighboring cells. Further examination showed that these mutations prevent fibrillin-1 from interacting with neighboring cells and lead to increased amounts and activity of TGFbeta, which causes excessive collagen outside cells.

The researchers then examined biopsies from patients with scleroderma and found all of the abnormalities seen in stiff skin syndrome. "It appears that fibriillin-1 helps to inform cells about the quality of their surroundings and also provides a mechanism — by concentrating TGFbeta — to induce extra cellular matrix production if the cell senses a deficiency," says Dietz. "A breakdown in signaling coupled with excessive fibrillin-1 and TGFbeta leads to a perfect storm for skin fibrosis in stiff skin syndrome."

While it remains unknown what triggers similar molecular events in scleroderma, these findings do suggest a number of potential treatment strategies, says Dietz.

Explore further: High blood-sugar levels may harden heart valves

Provided by Johns Hopkins Medical Institutions

4.5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Drug treatment for Marfan syndrome looks promising

Jun 26, 2008

A small study in 18 pattients assessing the effectiveness of the drug losartan for treating Marfan syndrome in children has yielded encouraging results. Reporting in the June 26 issue of The New England Journal of Medicine, Johns ...

Common blood pressure drug treats muscular dystrophy in mice

Jan 22, 2007

Researchers at Johns Hopkins have shown that a drug commonly used to lower blood pressure reverses muscle wasting in genetically engineered mice with Marfan syndrome and also prevents muscle degeneration in mice with Duchenne ...

Researchers discover gene signatures for scleroderma

Jul 16, 2008

Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report. Their discovery of distinguishing ...

Geneticists hunt for scleroderma triggers

Oct 29, 2009

At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, ...

Recommended for you

Team untangles the biological effects of blue light

16 hours ago

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

ironjustice
not rated yet Mar 21, 2010
This shows SPECIFICALLY the difference between vegetable fatty acid ingestion and animal fatty acid ingestion.

http://www.ncbi.n.../3688908

Deficiency of essential fatty acid (EFA) containing linoleic acid
(18:2n-6) in humans or animals induces morphologic changes
characterized by severe scaly dermatosis, extensive percutaneous water
loss, and hyperproliferation of the epidermis. Microscopically, the
epidermis is characterized by hyperkeratosis and acanthosis. The
refeeding of safflower oil containing linoleic acid or primrose oil
(containing linoleic acid [18:2n-6] and gamma-linolenic acid [18:3n-
6]) acids to EFA-deficient guinea pigs reverses the EFA-deficiency
symptoms. In contrast, replacement of safflower oil with menhaden fish
oil, (containing eicosapentaenoic acid [20:5n-3] and docosahexaenoic
acid [22:6n-3]) did not reverse the symptoms of EFA deficiency.